DCGI panel to review today SII applications for Covovax’s use among kids aged 2-7 years, 7-11 years Read more
Biological E gets WHO nod to be additional facility for making Johnson & Johnson COVID vaccine Read more
Ocugen announces positive results for COVID-19 vaccine trial for children aged two-18 years Read more